All times are listed in CET (Central European Time)

Browsing Over 190 Presentations

Sort By
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start? Young oncologists

Your perspective and personal story

Lecture Time
11:25 - 11:31
Speakers
  • J. Wolf (Köln, Germany)
Session Name
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start?
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • J. Wolf (Köln, Germany)
The eternal debate in stage III Multidisciplinary Tumour Board

Q&A and live discussion

Lecture Time
12:20 - 12:35
Speakers
  • A. Speakers (, Switzerland)
Session Name
The eternal debate in stage III
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • A. Speakers (, Switzerland)
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start? Young oncologists

Your perspective and personal story

Lecture Time
11:43 - 11:49
Speakers
  • F. Blackhall (Manchester, United Kingdom)
Session Name
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start?
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • F. Blackhall (Manchester, United Kingdom)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Q&A and live discussion

Lecture Time
12:20 - 12:35
Speakers
  • A. Speakers (, Switzerland)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • A. Speakers (, Switzerland)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Presentation of case: Monotherapy or chemoimmunotherapy in PD-L1>50%?

Lecture Time
11:15 - 11:20
Speakers
  • L. Landi (Ravenna, Italy)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • L. Landi (Ravenna, Italy)
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start? Young oncologists

Q&A and live discussion

Lecture Time
11:49 - 12:41
Speakers
  • A. Speakers (, Switzerland)
Session Name
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start?
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • A. Speakers (, Switzerland)
The eternal debate in stage III Multidisciplinary Tumour Board

Presentation of case

Lecture Time
11:15 - 11:20
Speakers
  • I. Browne (Dublin, Ireland)
Session Name
The eternal debate in stage III
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • I. Browne (Dublin, Ireland)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Options in patients with brain metastases

Lecture Time
11:20 - 11:35
Speakers
  • O. Gautschi (Luzern, Switzerland)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • O. Gautschi (Luzern, Switzerland)
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC Industry Satellite Symposium

The patient with an EGFR Exon 20 insertion: Expert insights and recommendations

Lecture Time
13:15 - 13:35
Speakers
  • M. Perol (Lyon, France)
Session Name
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC
Room
Channel 3
Date
Thu, 25.03.2021
Time
12:50 - 14:20
Authors
  • M. Perol (Lyon, France)
Novartis - Early treatment decisions in NSCLC: A debate on best practices Industry Satellite Symposium

The path to diagnosis in patients with NSCLC

Lecture Time
12:55 - 13:10
Speakers
  • M. Thomas (Heidelberg, Germany)
Session Name
Novartis - Early treatment decisions in NSCLC: A debate on best practices
Room
Channel 2
Date
Thu, 25.03.2021
Time
12:50 - 14:20
Authors
  • M. Thomas (Heidelberg, Germany)
MSD - Defining the standard of care in lung cancer Industry Satellite Symposium

A look into the future of NSCLC: Emerging treatment options

Lecture Time
13:35 - 13:50
Speakers
  • L. Paz-Ares (Madrid, Spain)
Session Name
MSD - Defining the standard of care in lung cancer
Room
Channel 1
Date
Thu, 25.03.2021
Time
12:50 - 14:20
Authors
  • L. Paz-Ares (Madrid, Spain)
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC Industry Satellite Symposium

Keeping up with the development in molecular testing for advanced NSCLC

Lecture Time
12:55 - 13:15
Speakers
  • K. Kerr (Aberdeen, United Kingdom)
Session Name
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC
Room
Channel 3
Date
Thu, 25.03.2021
Time
12:50 - 14:20
Authors
  • K. Kerr (Aberdeen, United Kingdom)